title: Adenocarcinoma of the small bowel.
abstract: Cancer of the small bowel is a rare entity but its incidence is rising. Historically, outcome is poor despite apparent curative resection. At present surgery remains the only treatment modality of proven benefit in the management of this disease. Recent data would suggest 5-year survival rates in the order of 40-50% at all sites of small bowel cancer. To improve upon this, earlier diagnosis with a high index of suspicion and multicentre adjuvant therapy trials are required.
authors.affiliation: King George Hospital, Essex, UK. rob@rhutchins.fsnet.co.uk
authors.forename: R R
authors.initials: RR
authors.lastname: Hutchins
authors.forename: A
authors.initials: A
authors.lastname: Bani Hani
authors.forename: P
authors.initials: P
authors.lastname: Kojodjojo
authors.forename: R
authors.initials: R
authors.lastname: Ho
authors.forename: S J
authors.initials: SJ
authors.lastname: Snooks
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology / Q000235:genetics / Q000601:surgery / Q000628:therapy; D006801:Humans; D007414:Intestinal Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000601:surgery / Q000628:therapy; D007421:Intestine, Small